XML 27 R13.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Revenue | 12 Months Ended
--- | ---
Dec. 31, 2023
Revenue from Contract with Customer [Abstract] |
Revenue | REVENUE Total revenues during the years ended December 31, 2023, 2022, and 2021 were as follows (in thousands):
| Year Ended December 31, |  |  |  |
| 2023 |  | 2022 |  | 2021 |  |  |  |  |  |  |
Product sales, net: |  |  |  |  |  |  |  |  |  |  |  |  |
IBSRELA | $ | 80,062 |  |  | $ | 15,600 |  |  | $ | — |  |  |  |  |  |  |  |  |
XPHOZAH | 2,464 |  |  | — |  |  | — |  |  |  |  |  |  |  |  |
Total product sales, net | 82,526 |  |  | 15,600 |  |  | — |  |  |  |  |  |  |  |  |
Licensing revenue | 35,809 |  |  | 35,031 |  |  | 5,013 |  |  |  |  |  |  |  |  |
Product supply revenue | 6,121 |  |  | 1,527 |  |  | 907 |  |  |  |  |  |  |  |  |
Collaborative development revenue | — |  |  | — |  |  | 4,177 |  |  |  |  |  |  |  |  |
Total revenues | $ | 124,456 |  |  | $ | 52,158 |  |  | $ | 10,097 |  |  |  |  |  |  |  |  |
Revenue from the following Customers who contributed greater than 10% of our gross product revenue during the years ended December 31, 2023 and 2022 as a percentage of total gross product revenue was as follows:
|  |  | Year Ended December 31,
|  |  |  |  | 2023 |  | 2022
BioRidge Pharma, LLC |  |  |  |  | 26.3 | % |  | — | %
Cardinal Health |  |  |  |  | 21.6 | % |  | 23.1 | %
AmerisourceBergen Drug Corporation |  |  |  |  | 20.9 | % |  | 26.8 | %
McKesson Corporation |  |  |  |  | 17.2 | % |  | 21.6 | %
The activities and ending reserve balances for each significant category of discounts and allowances, which constitute variable consideration, were as follows (in thousands):
| Discounts and Chargebacks |  | Rebates, Wholesaler and GPO Fees |  | Copay and Returns |  | Total
Balance as of December 31, 2021 | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Provisions | 825 |  |  | 2,721 |  |  | 2,502 |  |  | 6,048 |
Credits/payments | (683) |  |  | (1,277) |  |  | (1,244) |  |  | (3,204) |
Balance as of December 31, 2022 | 142 |  |  | 1,444 |  |  | 1,258 |  |  | 2,844 |
Provisions | 5,341 |  |  | 15,365 |  |  | 10,629 |  |  | 31,335 |
Credits/payments | (5,005) |  |  | (12,575) |  |  | (7,971) |  |  | (25,551) |
Balance as of December 31, 2023 | $ | 478 |  |  | $ | 4,234 |  |  | $ | 3,916 |  |  | $ | 8,628 |
Adjustments to prior period provisions recorded in the current period were not material.

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 606 -Publisher FASB -URI https://asc.fasb.org//606/tableOfContent + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration